Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system

Neurology

Volumn 37, Issue 7, 1987, Pages 1097-1102

  Panitch, Hillel S ^a,b   Hirsch, Robert L ^a   Schindler, John ^c   Johnson, Kenneth P ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DIAGNOSIS; HUMAN; IMMUNOLOGY; MULTIPLE SCLEROSIS; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; THERAPY;

ADULT; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION; MALE; MONOCYTES; MULTIPLE SCLEROSIS; PILOT PROJECTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023221133     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.37.7.1097     Document Type: Article

References (33)

1. McFarlin DE, McFarland HF. Multiple sclerosis. N Engl J Med 1982;307:1246–1251.
2. Oger J, Roos R, Antel JP. Immunology of multiple sclerosis. In: Antel JP, ed. Neurologic clinics. Philadelphia: WB Saunders, 1983:655–679.
3. Waksman BH, Reynolds WE. Multiple sclerosis as a disease of immune regulation. Proc Soc Exp Biol Med 1984;175:282–294.
4. Knobler RL, Panitch HS, Braheny SL, et al. Systemic alpha interferon therapy of multiple sclerosis. Neurology 1984;34:1273–1279.
5. Jacobs L, O’Malley J, Freeman A, Ekes R. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science 1981;214:1026–1028.
6. Jacobs L, Salazar AM, Herndon R, et al. Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis. Lancet 1986;2:1411–1413.
7. Camenga DL, Johnson KP, Alter M, et al. Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosis. Arch Neurol 1986;43:1239–1246.
8. Vilcek J, Gray PW, Rinderknecht E, Sevastopoulos CG. Interferon-gamma: a lymphokine for all seasons. In: Pick E, ed. Lymphokines, vol 11. New York Academic Press, 1985:1–32.
9. Basham TY, Merigan TC. Recombinant interferon-gamma increases HLA-DR synthesis and expression. J Immunol 1983;130:1492–1494.
10. Pober JS, Gimbone MA, Cotran RS, et al. Ia expression by vascular endothelium is inducible by activated T cells and by human interferon. J Exp Med 1983;157:1339–1353.
11. Fierz W, Endler B, Reske K, Wekerle H, Fontana A. Astrocytes as antigen-presenting cells, I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985;134:3785–3793.
12. Neighbour PA, Miller AE, Bloom BR. Interferon responses of leukocytes in multiple sclerosis. Neurology 1981;31:561–566.
13. Vervliet G, Claeys H, VanHaver H, et al. Interferon production and natural killer cell (NK) activity in leukocyte cultures from multiple sclerosis patients. J Neurol Sci 1983;60:137–150.
14. Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987;1:893–895.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
16. Sipe JC, Knobler RL, Braheny SL, Rice GPA, Panitch HS, Oldstone MBA. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 1984;34:1368–1372.
17. Hirsch RL, Panitch HS, Johnson KP. Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro. J Clin Immunol 1985;5:386–389.
18. Vervliet G, Carton H, Meulepas E, Billiau A. Interferon production by cultured peripheral leukocytes of MS patients. Clin Exp Immunol 1984;58:116–126.
19. Goust JM, Verselis SJ, Shums A. Interferon gamma and interleukin 2 (IL2) production in MS. Abstract. Neurology 1987;37(suppl 1):289.
20. Smith RA, Norris F, Palmer D, Bernhardt L, Wills RJ. Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration. Clin Pharmacol Ther 1985;37:85–88.
21. Kastrukoff LF, Paty DW. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis. Ann Neurol 1984;15:250–256.
22. Panitch HS, Francis GS, Hooper CJ, Merigan TC, Johnson KP. Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon. Ann Neurol 1985;18:434–438.
23. Kelley VE, Fiers W, Strom TB. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. J Immunol 1984;132:240–245.
24. Sobel RA, Blanchette BW, Bhan AK, Colvin RB. The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J Immunol 1984;132:2402–2407.
25. McCarron RM, Spatz M, Kempski O, Hogan RN, Muehl L, McFarlin DE. Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol 1986;137:3428–3435.
26. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis: distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983;4:201–221.
27. Traugott U, Raine CS. Multiple sclerosis: evidence for antigen presentation in situ by endothelial cells and astrocytes. J Neurol Sci 1985;69:365–370.
28. Hafler DA, Fox DA, Manning ME, Schlossman SF, Reinherz EL, Weiner HL. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985;312:1405–1411.
29. Noronha A, Richman DP, Arnason BGW. Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Ann Neurol 1985;18:722–725.
30. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985;1:1313–1315.
31. Waksman BH, Reingold SC. Viral etiology of multiple sclerosis: where does the truth lie? Trends Neuro Sci 1986;9:388–391.
32. Sriram S, Steinman L. Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J Exp Med 1983;158:1362–1367.
33. Ling PD, Warren MK, Vogel SN. Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages. J Immunol 1985;135:1857–1863.